DPM3: Difference between revisions
CSV import |
CSV import |
||
| Line 27: | Line 27: | ||
{{No image}} | {{No image}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 08:21, 17 March 2025
DPM3 (Dolichyl-phosphate mannosyltransferase subunit 3) is a protein that in humans is encoded by the DPM3 gene. This protein is part of the dolichol-phosphate mannose (Dol-P-Man) synthase complex. This complex is necessary for the synthesis of Dol-P-Man, which is essential for several glycosylation reactions.
Function[edit]
The DPM3 protein is a component of the dolichol-phosphate mannose (Dol-P-Man) synthase complex. This complex catalyzes the reaction that forms Dol-P-Man from GDP-mannose and dolichol phosphate. Dol-P-Man is an essential lipid-linked sugar donor used in several types of glycosylation reactions, including those involved in the synthesis of glycoproteins, glycolipids, and glycosylphosphatidylinositol (GPI) anchors.
Clinical significance[edit]
Mutations in the DPM3 gene are associated with a type of congenital disorder of glycosylation known as CDG-Io. This disorder is characterized by severe cardiomyopathy and a marked increase in serum creatine kinase levels. Patients with CDG-Io typically present with severe dilated cardiomyopathy and may also have skeletal myopathy, hepatomegaly, and coagulation abnormalities.
See also[edit]
References[edit]
<references />
External links[edit]

